A Juno and Celgene collaboration will focus on T cell therapeutics for cancer, one in eight people is pre-diabetic but a new study shows a willingness to change behavior if made aware of their risk.
Stephanie Baum | 7:30 am, July 2
Neil Versel | 11:34 am, July 2
Meghana Keshavan | 5:00 am, July 2
Chris Seper | 9:46 am, July 1